A small buyout deal gives a penny-stock biotech a boost and a second chance

Just over a month after former miRagen Therapeutics COO Lee Rauch stepped up to take the helm, the microcap is scooping up Viridian Therapeutics — and with it, a new lead candidate and $91 million boost.